Silexon AI

General Information

Company Name

Silexon AI

Founded Year

2018

Location (Offices)

Beijing, China +3

Founders / Decision Makers

Number of Employees

Industries

AI, Biotechnology, Machine Learning

Funding Stage

Series A

Social Media

Silexon AI - Company Profile

Silexon AI is an emerging Al-empowered drug discovery company founded in 2018 with the slogan "AI Empowers Drug Discovery and Life Sciences." This China-based startup aims to create an open Al platform for strategic collaboration in the biotechnology industry. Their AI/ML platform facilitates data-driven life science research and empowers drug innovation and development, ultimately leading to innovative drugs for unmet medical needs. Silexon AI recently secured Series A investment at 17 October 2019 from prominent investors like MSA Capital, Shengding Equity Investment Fund, and Prosperico Ventures. This investment serves as a testament to the potential and promise that Silexon AI holds in revolutionizing the field of drug discovery and life sciences.

Taxonomy: AI-empowered drug discovery, life science research, drug innovation, data-driven, drug development, drug big data, drug target panorama report, personalized cell therapy, small molecule virtual screening, Al platform, strategic collaboration, innovative drugs, unmet medical needs, Silexon